Evidence map›Paper›PMID 39796159›Full record

ArticleInternational journal of molecular sciences2024

Nanoscale Characterization of Interaction of Nucleosomes with H1 Linker Histone.

Ahmed Yesvi Rafa, Shaun Filliaux, Yuri L Lyubchenko

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ahmed Yesvi RafaDepartment of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE 68198-6025, USA.ORCID 0009-0003-4850-3678
Shaun FilliauxDepartment of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE 68198-6025, USA.ORCID 0000-0003-0462-5203
Yuri L LyubchenkoDepartment of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE 68198-6025, USA.ORCID 0000-0001-9721-8302

Funding

NIH HHS 1R01GM148537
6 · The paper itself

Abstract

In eukaryotic nuclei, DNA is wrapped around an octamer of core histones to form nucleosomes. H1 binds to the linker DNA of nucleosome to form the chromatosome, the next structural unit of chromatin. Structural features on individual chromatosomes contribute to chromatin structure, but not fully characterized. In addition to canonical nucleosomes composed of two copies each of histones H2A, H2B, H3, and H4 (H3 nucleosomes), centromeres chromatin contain nucleosomes in which H3 is replaced with its analog CENP-A, changing structural properties of CENP-A nucleosomes. Nothing is known about the interaction of H1 with CENP-A nucleosomes. Here we filled this gap and characterized the interaction of H1 histone with both types of nucleosomes. H1 does bind both types of the nucleosomes forming more compact chromosome particles with elevated affinity to H3 nucleosomes. H1 binding significantly increases the stability of chromatosomes preventing their spontaneous dissociation. In addition to binding to the entry-exit position of the DNA arms identified earlier, H1 is capable of bridging of distant DNA segments. H1 binding leads to the assembly of mononucleosomes in aggregates, stabilized by internucleosome interactions as well as bridging of the DNA arms of chromatosomes. Contribution of these finding to the chromatin structure and functions are discussed.

Indexed as

HistonesNucleosomesAnimalsCentromere Protein AChromatinDNAHumansProtein BindingCentromere Protein AChromatinDNAHistonesNucleosomesatomic force microscopy (AFM)chromatin compactionchromatosomegel electrophoresisH1 linker histoneNucleosome

Identifiers

PMID39796159
PMCPMC11719560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.